What is it about?

Ambulatory high dose methotrexate administration as CNS prophylaxis in non-Hodgkin lymphoma. Improve quality of life optimizing health resources.

Featured Image

Why is it important?

It shows the results of a study with ambulatory administration of high dose of high risk chemotherapy avoiding hospital addmissions.

Perspectives

Writing this article was a great pleasure as it has co-authors with whom I have had long standing collaborations.

RUBEN PAMPÍN

Read the Original

This page is a summary of: Experience with ambulatory high-dose methotrexate administration as CNS prophylaxis in patients with non-Hodgkin lymphoma, Journal of Oncology Pharmacy Practice, June 2019, SAGE Publications, DOI: 10.1177/1078155219852412.
You can read the full text:

Read

Resources

Contributors

The following have contributed to this page